The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: esomeprazole     Quarter: 2016Q3

Total Records: 283     Number of Pages: 15

DRUGNAME PT EventCount
ESOMEPRAZOLE MAGNESIUM. Oxygen consumption decreased 1
ESOMEPRAZOLE MAGNESIUM. Paranoia 1
ESOMEPRAZOLE MAGNESIUM. Pelvic fracture 1
ESOMEPRAZOLE MAGNESIUM. Pneumonia 1
ESOMEPRAZOLE MAGNESIUM. Posterior reversible encephalopathy syndrome 1
ESOMEPRAZOLE MAGNESIUM. Presyncope 1
ESOMEPRAZOLE MAGNESIUM. Product taste abnormal 1
ESOMEPRAZOLE MAGNESIUM. Renal impairment 1
ESOMEPRAZOLE MAGNESIUM. Retinal haemorrhage 1
ESOMEPRAZOLE MAGNESIUM. Rheumatoid arthritis 1
ESOMEPRAZOLE MAGNESIUM. Skin atrophy 1
ESOMEPRAZOLE MAGNESIUM. Somnolence 1
ESOMEPRAZOLE MAGNESIUM. Spinal column stenosis 1
ESOMEPRAZOLE MAGNESIUM. Suicidal ideation 1
ESOMEPRAZOLE MAGNESIUM. Thrombotic microangiopathy 1
ESOMEPRAZOLE MAGNESIUM. Vomiting 1
ESOMEPRAZOLE MYLAN Drug ineffective 1
ESOMEPRAZOLE MYLAN 20 MG G?LULES GASTRO-R?SISTANTES Acute kidney injury 1
ESOMEPRAZOLE MYLAN 20 MG G?LULES GASTRO-R?SISTANTES Cardiac arrest 1
ESOMEPRAZOLE MYLAN 20 MG G?LULES GASTRO-R?SISTANTES Disseminated intravascular coagulation 1

Total Records: 283     Number of Pages: 15